| Title | Date | PubMed ID |
|---|
| Anthrax toxin lethal factor domain 3 is highly mobile and responsive to ligand binding. | 2014 Nov | 25372673 |
| High metal substitution tolerance of anthrax lethal factor and characterization of its active copper-substituted analogue. | 2014 Nov | 25042732 |
| Inhibition of anthrax lethal factor by curcumin and chemically modified curcumin derivatives. | 2014 Oct | 24102525 |
| NMR conformational properties of an Anthrax Lethal Factor domain studied by multiple amino acid-selective labeling. | 2014 Jul 18 | 24944022 |
| Anthrax lethal toxin inhibits translation of hypoxia-inducible factor 1α and causes decreased tolerance to hypoxic stress. | 2014 Feb 14 | 24366872 |
| Small-molecule inhibitors of lethal factor protease activity protect against anthrax infection. | 2013 Sep | 23774434 |
| Effect of pH on the catalytic function and zinc content of native and immobilized anthrax lethal factor. | 2013 Feb 14 | 23313942 |
| Cytotoxicity of anthrax lethal toxin to human acute myeloid leukemia cells is nonapoptotic and dependent on extracellular signal-regulated kinase 1/2 activity. | 2013 Feb | 23418614 |
| Binding and cell intoxication studies of anthrax lethal toxin. | 2012 May | 22219086 |
| Anthrax lethal toxin disrupts the endothelial permeability barrier through blocking p38 signaling. | 2012 Apr | 21618534 |